Thilo Schlott

1.1k total citations
51 papers, 855 citations indexed

About

Thilo Schlott is a scholar working on Oncology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Thilo Schlott has authored 51 papers receiving a total of 855 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Oncology, 21 papers in Molecular Biology and 11 papers in Pathology and Forensic Medicine. Recurrent topics in Thilo Schlott's work include Cancer-related Molecular Pathways (14 papers), Immunotherapy and Immune Responses (7 papers) and Cancer Genomics and Diagnostics (6 papers). Thilo Schlott is often cited by papers focused on Cancer-related Molecular Pathways (14 papers), Immunotherapy and Immune Responses (7 papers) and Cancer Genomics and Diagnostics (6 papers). Thilo Schlott collaborates with scholars based in Germany, United States and Poland. Thilo Schlott's co-authors include I Ruschenburg, E. Kunze, M Droese, M Korabiowska, Afsaneh Soruri, Helmut Eiffert, Afshin Fayyazi, Holger Nagel, Paul Thelen and Ulrich Brinck and has published in prestigious journals such as The Journal of Immunology, American Journal of Obstetrics and Gynecology and The Journal of Urology.

In The Last Decade

Thilo Schlott

51 papers receiving 833 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thilo Schlott Germany 18 390 266 139 132 116 51 855
Helen Fernandes United States 17 344 0.9× 206 0.8× 79 0.6× 195 1.5× 163 1.4× 36 916
Takao Kinjo Japan 18 230 0.6× 227 0.9× 195 1.4× 158 1.2× 87 0.8× 57 967
Wichai Pornthanakasem Thailand 14 353 0.9× 289 1.1× 118 0.8× 52 0.4× 201 1.7× 19 812
Stefano Barca Italy 14 307 0.8× 118 0.4× 109 0.8× 124 0.9× 43 0.4× 28 743
Adriana Contreras‐Paredes Mexico 19 517 1.3× 219 0.8× 126 0.9× 177 1.3× 250 2.2× 43 1.1k
Christopher A. Lundquist United States 8 740 1.9× 346 1.3× 51 0.4× 174 1.3× 116 1.0× 9 1.3k
Mikiko Aoki Japan 19 241 0.6× 233 0.9× 107 0.8× 70 0.5× 104 0.9× 108 1.2k
Irene Kuhn United States 14 444 1.1× 383 1.4× 32 0.2× 145 1.1× 99 0.9× 21 1.0k
Bert Top Netherlands 17 419 1.1× 375 1.4× 251 1.8× 42 0.3× 164 1.4× 31 990
H. Kaufmann Austria 23 907 2.3× 549 2.1× 87 0.6× 87 0.7× 92 0.8× 71 1.7k

Countries citing papers authored by Thilo Schlott

Since Specialization
Citations

This map shows the geographic impact of Thilo Schlott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thilo Schlott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thilo Schlott more than expected).

Fields of papers citing papers by Thilo Schlott

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thilo Schlott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thilo Schlott. The network helps show where Thilo Schlott may publish in the future.

Co-authorship network of co-authors of Thilo Schlott

This figure shows the co-authorship network connecting the top 25 collaborators of Thilo Schlott. A scholar is included among the top collaborators of Thilo Schlott based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thilo Schlott. Thilo Schlott is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schlott, Thilo, et al.. (2008). Detection and analysis of cancer genes amplified from bone material of a Scythian royal burial in Arzhan near Tuva, Siberia.. PubMed. 27(6B). 4117–9. 6 indexed citations
2.
3.
Eiffert, Helmut, A. Karsten, Klaus Ritter, et al.. (2005). Autoantibodies to Human Manganese Superoxide Dismutase (MnSOD) in Children with Facial Palsy due to Neuroborreliosis. Neuropediatrics. 36(6). 386–388. 3 indexed citations
4.
Schweyer, Stefan, Afsaneh Soruri, Nicolai Miosge, et al.. (2004). Cisplatin-induced apoptosis in human malignant testicular germ cell lines depends on MEK/ERK activation. British Journal of Cancer. 91(3). 589–598. 88 indexed citations
5.
6.
Korabiowska, M, Fatima König, Raphaela Verheggen, et al.. (2004). Altered expression and new mutations in DNA mismatch repair genes MLH1 and MSH2 in melanoma brain metastases.. PubMed. 24(2B). 981–6. 12 indexed citations
7.
Korabiowska, M, et al.. (2004). Down-regulation of Ku 70 and Ku 80 mRNA expression in transitional cell carcinomas of the urinary bladder related to tumor progression. World Journal of Urology. 22(6). 431–440. 10 indexed citations
8.
Soruri, Afsaneh, et al.. (2003). Anaphylatoxin C5a Induces Monocyte Recruitment and Differentiation into Dendritic Cells by TNF-α and Prostaglandin E2-Dependent Mechanisms. The Journal of Immunology. 171(5). 2631–2636. 57 indexed citations
9.
Schlott, Thilo, et al.. (2003). Abundant Expression of Spliced HDM2 in Hodgkin Lymphoma Cells does not Interfere with p14ARFand p53 Binding. Leukemia & lymphoma. 44(9). 1587–1596. 2 indexed citations
10.
Täubert, Helge, Katja Schuster, Ulrich Brinck, et al.. (2003). Loss of Heterozygosity at 12q14-15 Often Occurs in Stage I Soft Tissue Sarcomas and Is Associated with MDM2 Amplification in Tumors at Various Stages. Modern Pathology. 16(11). 1109–1116. 8 indexed citations
11.
Korabiowska, M, et al.. (2002). GADD153 is an independent prognostic factor in melanoma: immunohistochemical and molecular genetic analysis.. PubMed. 17(3). 805–11. 17 indexed citations
12.
13.
Nagel, Holger, et al.. (2001). Gene Expression Analysis of the Catalytic Subunit of Human Telomerase (hEST2) in the Differential Diagnosis of Serous Effusions. Diagnostic Molecular Pathology. 10(1). 60–65. 4 indexed citations
14.
Täubert, Helge, Matthias Kappler, Axel Meye, et al.. (2000). A MboII polymorphism in exon 11 of the human MDM2 gene occuring in normal blood donors and in soft tissue sarcoma patients: an indication for an increased cancer susceptibility?. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 456(1-2). 39–44. 4 indexed citations
15.
Korabiowska, M, Ulrich Brinck, I Ruschenburg, et al.. (1999). Bcl2 and Bax expression in naevi and melanomas and their relation to ploidy status and proliferation.. PubMed. 50(1). 17–21. 8 indexed citations
16.
Schlott, Thilo, et al.. (1999). Different gene expression of MDM2, GAGE-1, –2 and FHIT in hepatocellular carcinoma and focal nodular hyperplasia. British Journal of Cancer. 80(1-2). 73–78. 23 indexed citations
17.
Schlott, Thilo, et al.. (1998). The In Situ Polymerase Chain Reaction for Detection of Chlamydia trachomatis. Journal of Histochemistry & Cytochemistry. 46(9). 1017–1023. 14 indexed citations
18.
Soruri, Afsaneh, Afshin Fayyazi, Robert K. Gieseler, et al.. (1998). Specific Autologous Anti-Melanoma T Cell Response in vitro Using Monocyte-Derived Dendritic Cells. Immunobiology. 198(5). 527–538. 16 indexed citations
19.
Rössler, Dieter, Helmut Eiffert, S. Jauris-Heipke, et al.. (1995). Molecular and immunological characterization of the p83/100 protein of various Borrelia burgdorferi sensu lato strains. Medical Microbiology and Immunology. 184(1). 23–32. 24 indexed citations
20.
Scriba, M., et al.. (1993). The 39-kilodalton protein of Borrelia burgdorferi: a target for bactericidal human monoclonal antibodies. Infection and Immunity. 61(10). 4523–4526. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Helen Fernandes Breakdown of academic impact, for papers by Takao Kinjo Breakdown of academic impact, for papers by Wichai Pornthanakasem Breakdown of academic impact, for papers by Stefano Barca Breakdown of academic impact, for papers by Adriana Contreras‐Paredes Breakdown of academic impact, for papers by Christopher A. Lundquist Breakdown of academic impact, for papers by Mikiko Aoki Breakdown of academic impact, for papers by Irene Kuhn Breakdown of academic impact, for papers by Bert Top Breakdown of academic impact, for papers by H. Kaufmann
Rankless by CCL
2026